ACTA1 and colorectal carcinoma: Patients with lower expression of αSMA within the TME of solid tumors, such as in PDAC, HNSCC, and CRC [63,64], tend to have worse prognosis, further supporting the interpretation that αSMA+ CAFs restrict tumor growth.